INDEMNIFICATION AGREEMENT by and between CBD Life Sciences, Inc. and Lisa Nelson indemniteeIndemnification Agreement • May 22nd, 2019 • CBD Life Sciences Inc. • California
Contract Type FiledMay 22nd, 2019 Company Jurisdiction
SUBSCRIPTION AGREEMENT CBD Life Sciences, Inc. NOTICE TO INVESTORSSubscription Agreement • August 18th, 2022 • CBD Life Sciences Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledAugust 18th, 2022 Company Industry JurisdictionThe securities of CBD Life Sciences, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. Investors should further understand that this investment is illiquid and is expected to continue to be illiquid for an indefinite period of time. No public market exists for the securities to which this Subscription Agreement relates.
EMPLOYMENT AGREEMENTEmployment Agreement • May 22nd, 2019 • CBD Life Sciences Inc.
Contract Type FiledMay 22nd, 2019 Company
CBD Life Sciences, Inc. SUBSCRIPTION AGREEMENTSubscription Agreement • August 7th, 2019 • CBD Life Sciences Inc. • Medicinal chemicals & botanical products • Maryland
Contract Type FiledAugust 7th, 2019 Company Industry JurisdictionTHIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
CBD Life Sciences, Inc. SUBSCRIPTION AGREEMENTSubscription Agreement • June 29th, 2021 • CBD Life Sciences Inc. • Medicinal chemicals & botanical products • Arizona
Contract Type FiledJune 29th, 2021 Company Industry JurisdictionTHIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • September 23rd, 2020 • CBD Life Sciences Inc. • Medicinal chemicals & botanical products
Contract Type FiledSeptember 23rd, 2020 Company IndustryAnd whereas the Company considers it both appropriate and necessary to issue Preferred shares of the Company in satisfaction of a portion of the Debt and the Creditor is willing to accept Preferred shares of the Company in satisfaction of a portion of the Debt.